VEGF-A/sVEGFR-2 ratio was significantly elevated in ovarian cancer patients compared to patients with benign ovarian tumor (40% higher, P < 0.05, respectively) (Table 1, Figure 1D). The gene discussed is VEGFA; the disease is ovarian benign neoplasm.